Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma

PURPOSE: Symptomatic epilepsy is a common complication of glioblastoma and requires pharmacotherapy. Several uncontrolled retrospective case series and a post hoc analysis of the registration trial for temozolomide indicated an association between valproic acid (VPA) use and improved survival outcom...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Oncol
Egile Nagusiak: Happold, Caroline, Gorlia, Thierry, Chinot, Olivier, Gilbert, Mark R., Nabors, L. Burt, Wick, Wolfgang, Pugh, Stephanie L., Hegi, Monika, Cloughesy, Timothy, Roth, Patrick, Reardon, David A., Perry, James R., Mehta, Minesh P., Stupp, Roger, Weller, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2016
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070573/
https://ncbi.nlm.nih.gov/pubmed/26786929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.63.6563
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak